An open science approach to target DIPG, an incurable pediatric brain cancer

OICR Mondays: "An open science approach to target DIPG, an incurable pediatric brain cancer"
Moderator: Dr. Aled Edwards, Professor, Molecular Genetics, University of Toronto
Current treatment options and clinical trials landscape of DIPG: Dr. Anirban Das, Staff Physician, Neuro-Oncology, SickKids
Molecular drivers of DIPG: Evan Lubanszky, Graduate Student (Dr. Cynthia Hawkins, SickKids)
Designing brain-penetrant ALK2 inhibitors for DIPG: Hector Gonzalez Alvarez, Graduate Student (Dr. Rima Al-awar, OICR Drug Discovery Program)